Acupuncture modification treatment for female sexual dysfunction: A meta-analysis.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 03 07 2023
revised: 17 09 2023
accepted: 26 09 2023
medline: 24 11 2023
pubmed: 9 10 2023
entrez: 8 10 2023
Statut: ppublish

Résumé

Acupuncture has potential in the treatment of female sexual dysfunction (FSD), but its effectiveness needs to be verified. A meta-analysis to provide a summary of studies that had investigated the efficacy of acupuncture as a treatment for FSD. A systematic screening was conducted on electronic databases such as Pubmed, Embase, Cochrane Library, CNKI, and CBM to select studies that met the criteria before April 2023. We only included those studies assessing women's sexual functioning by the Female Sexual Function Index (FSFI). By calculating the relative risk (RR) using the standardized mean difference (SMD) and 95% confidence interval (CI), these data were combined to generate a summary of the findings. The pooled results were calculated using a random-effects model. A total of 4 studies involving 178 participants were included, and the comprehensive results indicated a significant difference in FSFI scores between the acupuncture group and the control group. In the desire and arousal scale, there was a statistically significant difference between the acupuncture group and the control group. But in the scale of lubrication, orgasm, satisfaction, and pain, there was no statistically significant difference between the two groups. A comparison of overall FSFI scores, sexual desire, and sexual arousal revealed that acupuncture treatment can improve female sexual dysfunction to some extent. However, in terms of vaginal lubrication, orgasm, sexual satisfaction, and sexual pain, acupuncture treatment did not significantly improve female sexual dysfunction. In the future, it is necessary to include more RCT trials and expand the number of patients analyzed to make the conclusions more reliable.

Sections du résumé

BACKGROUND BACKGROUND
Acupuncture has potential in the treatment of female sexual dysfunction (FSD), but its effectiveness needs to be verified.
AIM OBJECTIVE
A meta-analysis to provide a summary of studies that had investigated the efficacy of acupuncture as a treatment for FSD.
METHODS METHODS
A systematic screening was conducted on electronic databases such as Pubmed, Embase, Cochrane Library, CNKI, and CBM to select studies that met the criteria before April 2023. We only included those studies assessing women's sexual functioning by the Female Sexual Function Index (FSFI).
OUTCOMES RESULTS
By calculating the relative risk (RR) using the standardized mean difference (SMD) and 95% confidence interval (CI), these data were combined to generate a summary of the findings. The pooled results were calculated using a random-effects model.
RESULTS RESULTS
A total of 4 studies involving 178 participants were included, and the comprehensive results indicated a significant difference in FSFI scores between the acupuncture group and the control group. In the desire and arousal scale, there was a statistically significant difference between the acupuncture group and the control group. But in the scale of lubrication, orgasm, satisfaction, and pain, there was no statistically significant difference between the two groups.
CONCLUSION CONCLUSIONS
A comparison of overall FSFI scores, sexual desire, and sexual arousal revealed that acupuncture treatment can improve female sexual dysfunction to some extent. However, in terms of vaginal lubrication, orgasm, sexual satisfaction, and sexual pain, acupuncture treatment did not significantly improve female sexual dysfunction. In the future, it is necessary to include more RCT trials and expand the number of patients analyzed to make the conclusions more reliable.

Identifiants

pubmed: 37806029
pii: S0301-2115(23)00748-0
doi: 10.1016/j.ejogrb.2023.09.026
pii:
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-33

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Shuangcheng Ning (S)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China; Department of Pharmacy, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China. Electronic address: sc_ning1995@163.com.

Shasha Liu (S)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China; Department of Pharmacy, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China. Electronic address: lss10188498@163.com.

Xiangyu Chen (X)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China; Department of Pathology, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China. Electronic address: chenxiangyu@cssfybjy.com.

Jin Wang (J)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China; Department of Pharmacy, Changsha Hospital for Maternal & Child Care Affiliated to Hunan Normal University, Changsha, China. Electronic address: 18673220050@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH